Basking Biosciences
Basking Biosciences is a clinical-stage biopharmaceutical company in Research Triangle, North Carolina (with operations in Mitchelton, Queensland, Australia) developing novel therapies for life-threatening blood clots. Its lead program BB-031 is an investigational RNA aptamer that targets von Willebrand Factor (vWF) to deliver a rapid-onset, targeted, and reversible thrombolytic for acute ischemic stroke, paired with BB-025, a direct-acting reversal agent designed to rapidly neutralize BB-031. The company is running the RAISE Phase 2 clinical trial and is backed by Insight Partners. Surfaced as a VC portfolio company and added to the API Evangelist network; the company publishes no public developer API, SDK, or documentation surface, so this profile carries company identity only.
Basking Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotech Therapeutics, Biopharmaceutical, Clinical Stage, and Stroke.
Basking Biosciences’ developer surface includes engineering blog and 5 more developer resources.
Kin Score
Resources
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API